Pad Chivukula Net Worth & Insider Trades

Pad Chivukula - Chief Scientific Officer & COO, Arcturus Therapeutics Holdings Inc

As of November 3, 2023

What is Pad Chivukula's Net Worth?

The current estimated net worth of Arcturus Therapeutics Holdings Inc's Chief Scientific Officer & COO, Pad Chivukula, is estimated to be about $21.73M . Pad Chivukula owns about 499,448 units of Arcturus Therapeutics Holdings Inc common stock. In the last 4 years at Arcturus Therapeutics Holdings Inc, Pad Chivukula has sold an estimated value of $9.95M worth.

What is Pad Chivukula's Past Insider Trading?

Pad Chivukula's largest sale order was 10,000 units , worth over $961.9K on December 3, 2020. In total, Pad Chivukula has made about 31 transactions over 4 years of their time at Arcturus Therapeutics Holdings Inc. Pad Chivukula usually trades in December, with the busiest year in 2023. The most recent transaction was a sale order of 5,000 units , worth over $93.6K on November 3, 2023.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

Pad Chivukula

Date Range: All Time
Price per Share
Filing Date
No matching records found


Our partner InsideArbitrage provides a full suite of tools and analysis that allows you to find opportunities from the hundreds of insiders transactions filed by company insiders each week. The service includes the popular Insider Weekends articles that highlight the top 5 insider purchases and sales each week as well as detailed analysis of one company each week. The service also includes several custom screens such as the Double Dipper that includes a list of companies that are buying back their shares while their insiders are independently buying stock on the open market for their own portfolios.

What was Pad Chivukula's Salary in 2020?

As Chief Scientific Officer & COO of Arcturus Therapeutics Holdings Inc, Pad Chivukula has a total base salary of $400,000 . Pad Chivukula received compensation valued at about $7,472,600 in 2020 after becoming Chief Scientific Officer & COO. The vast majority of their compensation came in the form of a bonus of $240,000 , option awards of $6,832,600 , and

What is Pad Chivukula's' Mailing Address?

  • Mailing address is 10628 Science Center Drive Suite 200 San Diego CA 92121 CA

Arcturus Therapeutics Holdings Inc Executive Compensation

Option Awards
Other Compensation
Joseph E. Payne 2020 $500,000 $450,000 $11,911,500 - $12,861,500
Joseph E. Payne 2019 $450,000 $243,000 $472,818 - $1,165,818
Joseph E. Payne 2018 $425,000 $372,532 $636,888 $1,252,624 $2,687,044
Dr. Padmanabh Chivukula 2020 $400,000 $240,000 $6,832,600 - $7,472,600
Dr. Padmanabh Chivukula 2019 $370,000 $133,200 $132,956 - $636,156
Dr. Padmanabh Chivukula 2018 $350,000 $83,233 $424,592 $515,080 $1,372,905
Andy Sassine, 2020 $400,000 $240,000 $7,014,800 - $7,654,800
Andy Sassine, 2019 $375,000 $150,000 $801,880 - $1,326,880
Andy Sassine, 2018 $120,000 - $126,340 - $246,340
Dr. Steven Hughes 2020 $415,000 $249,000 $4,212,625 - $4,876,625
Dr. Steven Hughes 2019 $299,873 - - - $299,873
Lance Kurata 2020 $156,250 $67,500 $4,916,800 - $5,140,550
No matching records found


What are Arcturus Therapeutics Holdings Inc's Past Insider Trades?

Arcturus Therapeutics Holdings Inc's most recent insider trade came on November 3, 2023 by Pad Chivukula who sold 5,000 units worth $93.6K . In the last 4 years, insiders at Arcturus Therapeutics Holdings Inc have sold an estimated value of $134.67M and bought an estimated value of $10.53M worth of shares. Insider trading is most common in June, with the busiest year in 2020. The most active traders at the company are Pad Chivukula, Chief Scientific Officer & COO,  Andy Sassine, Chief Financial Officer,  and Keith Kummerfeld, See Remarks .

Arcturus Therapeutics Ltd. Insider Trades

Date Range: All Time
Insider Names
Price per Share
Filing Date
No matching records found